In regard to Solomon et al.: EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. IJROBP 2003;55:713-723.
Krause
Mechthild
M
Baumann
Michael
M
Thames
Howard D
HD
D000818:Animals; D017209:Apoptosis / Q000528:radiation effects; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D002455:Cell Division / Q000528:radiation effects; D019583:Dose Fractionation, Radiation; D016228:Endothelial Growth Factors / Q000378:metabolism; D004815:Epidermal Growth Factor / Q000037:antagonists & inhibitors*; D005260:Female; D051379:Mice; D008819:Mice, Nude; D011799:Quinazolines / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D011879:Radiotherapy Dosage; D014407:Tumor Cells, Cultured / Q000528:radiation effects
D016228:Endothelial Growth Factors; D011799:Quinazolines; D011838:Radiation-Sensitizing Agents; D004815:Epidermal Growth Factor